Polypeptide autoantigens associated with endometriosis

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007100, C424S185100

Reexamination Certificate

active

10172573

ABSTRACT:
This invention provides a polynucleotide encoding Repro-EN-1.0 and IB1, polypeptides associated with endometriosis. Auto-antibodies against Repro-EN-1.0 and IB1 have been found in subjects diagnosed with endometriosis. This invention also provides methods of using this polynucleotide and polypeptide.

REFERENCES:
patent: WO94/28021 (1994-12-01), None
Colman, “effects of amino acid sequence changes on antibody-antigen interactions,” research in Immunology, 1994, 145:33-36.
Voorhis et al., J Reprod Immunol, 1997, 33:239-256.
Walter et al., J Autoimmun, 1995, 8:931-45.
Emest24 Database Entry Hs888330 Accession No. W19888; May 5, 1996 Hillier et al.: “The WashU-Merck EST Project” XP002126944.
EMBL Database Entry AI832097 Accession No. AI832097; Jul. 13, 1999 Robert Strausberg XP002141979.
Van Regenmortel, M.,Methods: A Companion to Metohds in Enzymology, 9:465-472, 1966.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Polypeptide autoantigens associated with endometriosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptide autoantigens associated with endometriosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide autoantigens associated with endometriosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3938485

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.